ARCHIVE

• DIAGNOSTIC NEWS IN BRIEF
  April 11, 2005

• Council for Unapproved Drugs Examines Natalizumab, Bortezumib
  April 11, 2005

• Chuikyo Approves Listing of 3 Drugs Including Oxaliplatin
  April 11, 2005

• Study Group on Clinical Trials Holds 1st Meeting
  April 11, 2005

• MREAC Finalizes Activities Plan for FY2005
  April 11, 2005

• Pfizer Japan Maintains Lead in MR Calls: MOSS Institute
  April 11, 2005

• Rules on Sale of Ethical Drugs Clarified
  April 11, 2005

• 1st 3Qtrs Business Results
  April 11, 2005

• PMDA to Answer Complaints within 15 Days
  April 11, 2005

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  April 11, 2005

• REGULATORY NEWS IN BRIEF
  April 11, 2005

• The Reporter's Eye: 4
  April 11, 2005

• Hospitals' Attitudes toward Health Foods Vary: Survey
  April 4, 2005

• Gov't Approves 3-year Plan for Regulatory Reform
  April 4, 2005

• DIAGNOSTIC NEWS IN BRIEF
  April 4, 2005

• Korosho to Relax Approval Requirements for Combination Drugs
  April 4, 2005

• The Reporter's Eye: 2
  April 4, 2005

• Recommendation on Use of Iressa Compiled
  April 4, 2005

• OTC NEWS IN BRIEF
  April 4, 2005

• Chugai's Actemra, Actelion's Tracleer to Be Approved in April
  April 4, 2005

ページ

• « 先頭
• ‹ Prev
• …
• 472
• 473
• 474
• 475
• 476
• 477
• 478
• 479
• 480
• …
• Next ›
• 最終 »